Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice

(2011) Danielle A Eekman et al.   BMC MUSCULOSKELETAL DISORDERS

Management of Skeletal Health in Patients With Asymptomatic Primary Hyperparathyroidism

(2010) E. Michael Lewiecki   JOURNAL OF CLINICAL DENSITOMETRY

Secondary osteoporosis in patients with an osteoporotic fracture

(2009) C. Kok et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy

(2009) A. Rogers et al.   BONE

Osteoporosis in men

(2008) Jean M. Kaufman et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Establishing a reference range for bone turnover markers in young, healthy women

(2008) S.J. Glover et al.   BONE